Skip to main content

Advertisement

Log in

Effect of transtympanic betamethasone delivery to the inner ear

  • Otology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

To investigate the effect of transtympanic betamethasone administration on hearing function with histologic correlation, rats were divided into three transtympanic treatment groups: isotonic saline (group I, n = 10), gentamicin (group II, n = 10) and betamethasone (group III, n = 10). Distortion product otoacoustic emission thresholds were compared on day 10. Also histological effects on cellular apoptosis in both the inner and outer hair cells in organ of Corti and spiral ganglion neurons were evaluated. Distortion product otoacoustic emission thresholds were comparable (p > 0.05) between group I and group III in all measurements. Distortion product otoacoustic emission thresholds of group II were significantly elevated in all measurements when compared with group I (p < 0.05) and group III (p < 0.05). In the Terminal deoxynucleotidyl transferase dUTP Nick End Labelling (TUNEL), Caspase-3, Caspase-8 and Caspase-9 staining method the amount of apoptotic cells in group II were significantly elevated in all measurements compared with group I (p < 0.05). In the TUNEL staining method the amount of apoptotic cells in Group III were significantly elevated compared with group I in both the organ of Corti and spiral ganglion neurons (p < 0.05). The overall histological results revealed that the severity of cellular apoptosis caused by betamethasone was somewhere between isotonic saline and gentamicin. Transtympanic betamethasone does not affect inner ear function as measured by distortion product otoacoustic emission responses, but some increase in cellular apoptosis in the organ of Corti and spiral ganglion neurons was observed. These findings suggest that transtympanic betamethasone may have mild ototoxic effects. Further studies are needed to obtain precise results for transtympanic application of betamethasone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ (2007) Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 28:1124–1130

    Article  PubMed  Google Scholar 

  2. Plontke SK, Biegner T, Kammerer B, Delabar U, Salt AN (2008) Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 29:401–406

    Article  PubMed  Google Scholar 

  3. Ozdogan F, Ensari S, Cakir O et al (2012) Investigation of the cochlear effects of intratympanic steroids administered following acoustic trauma. Laryngoscope 122:877–882

    Article  CAS  PubMed  Google Scholar 

  4. Suzuki H, Hashida K, Nguyen KH et al (2012) Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope 122:1154–1157

    Article  CAS  PubMed  Google Scholar 

  5. Van Rensburg K (2011) A guide to prescribing corticosteroids: review. SA Pharm J 78:32–38

    Google Scholar 

  6. Shimogori H, Yamashita H (2000) Efficacy of intracochlear administration of betamethasone on peripheral vestibular disorder in the guinea pig. Neurosci Lett 294:21–24

    Article  CAS  PubMed  Google Scholar 

  7. Worsøe L, Brandt CT, Lund SP, Ostergaard C, Thomsen J, Cayé-Thomasen P (2010) Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis. Otol Neurotol 31:394–403

    Article  PubMed  Google Scholar 

  8. Blakley BW, Alsaleh S, Dewji Z, Qureshy K, Berard S, Xie L (2014) Steroids in aminoglycoside-containing ear drops: do they reduce cochlear toxicity? Laryngoscope 124:1209–1213

    Article  CAS  PubMed  Google Scholar 

  9. Marais J, Rutka JA (1998) Ototoxicity and topical eardrops. Clin Otolaryngol Allied Sci 23:360–367

    Article  CAS  PubMed  Google Scholar 

  10. Sakamoto T, Nakagawa T, Horie RT et al (2010) Inner ear drug delivery system from the clinical point of view. Acta Otolaryngol Suppl 563:101–104

    Article  CAS  PubMed  Google Scholar 

  11. Horie RT, Sakamoto T, Nakagawa T, Ishihara T, Higaki M, Ito J (2010) Stealth-nanoparticle strategy for enhancing the efficacy of steroids in mice with noise-induced hearing loss. Nanomedicine (Lond) 5:1331–1340

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Si-Ser Hearing Center for their support for distortion product-evoked otoacoustic emission testing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Halil Erdem Özel.

Ethics declarations

Conflict of interest

We have no conflict of interest.

Ethical approval

All applicable international, national and/or institutional guidelines for the care and use of animals were followed.

Financial disclosure

Kocaeli Derince Research and Training Hospital has provided financial support for this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özel, H.E., Özdoğan, F., Gülşen Gürgen, S. et al. Effect of transtympanic betamethasone delivery to the inner ear. Eur Arch Otorhinolaryngol 273, 3053–3061 (2016). https://doi.org/10.1007/s00405-016-3905-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-3905-9

Keywords

Navigation